Logo

Home

smallArrow

Stocks Screener

smallArrow

Jubilant Pharmova

Jubilant Pharmova Share Price

Jubilant Pharmova (INR)1206.132.4   (2.8%)

Exchange ScripsBSE530019NSEJUBLPHARMAISININE700A01033

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Jubilant Pharmova Performance

Market performance
Open price1189.8
High1213.2
Volumes513293
Prev Close1206.1
Low1139.9
Closing date2024-09-20
Historical performance
1 Year High1247.15
3 Year High1247.15
5 Year High1247.15
1 Year Low318.75
3 Year Low268.90
5 Year Low234.35

Jubilant Pharmova Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
10391
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
247.17
Dividend Yield
Dividend Yield
0.41 %

Jubilant Pharmova Investment Returns

1 Year
175.6%
3 Years
99.1%
5 Years
125.4%
10 Years
597.6%

Jubilant Pharmova Technicals

IndicatorsValueSignal
5-DMA1204.46Bullish
10-DMA1134.22Bullish
20-DMA1029.66Bullish
50-DMA894.52Bullish
100-DMA805.22Bullish
200-DMA689.67Bullish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters1212121212
Foreign Investors22222
Domestic Investors1010101010
Public Investors8198092252865768936493363
Government---------------

Jubilant Pharmova Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income687383113176
Operating Profit969581451167614141
Interest2723188214551841
Depreciation3819554038173489
Profit Before Tax170527863048711
Consolidated Net Profit771-61041398359
Adjusted EPS5-42653

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital158159159159
Total Reserves54036537725299047248
Minority Interest-128-75-22---
Total Non-Current Liabilities40057376502921629730
Total Liabilities1131581092929829687634
Capital Work in Progress12523773329182778
Total Assets1131581092929829687634

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities97136607837517843
Cash Flow from Investing Activities-6079-5444-3804-7390
Cash Flow from Financing Activitie-4325-1567-326-17094
Net Cash Inflow / Outflow-691-4044246-6641
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 247.17.
  • 3Y Stock Price CAGR of the stock is 25.0.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹9695 Million.
  • The company generated revenue of ₹67029 Million in the previous financial year.

Jubilant Pharmova

1206.132.4   (2.8%)

Investment Amount: ₹ 43150
Current Value: ₹ 120610
Performence: 179.5%
P/L: ₹ 77460
Top Gainers
SymbolChange%
ITDCEM562.45(19%)
MARKSANS318.35(16%)
CONCORDBIO2601.1(16%)
MAGADSUGAR957.45(14%)
PRSMJOHNSN219.54(12%)
Top Losers
SymbolChange%
ROSSELLIND170.85(-73%)
SADHNANIQ59.21(-9%)
BHARATRAS11914.5(-7%)
PEARLPOLY42.08(-7%)
SAKSOFT276.15(-7%)
AGIIL1042.6(-6%)
GATECH1.17(-6%)
XTGLOBAL41.63(-6%)
Similar stocks

Panacea Biotec

▲ 62.2

314.09

August 20 - September 20

Concord Biotech

▲ 57.1

2601.1

August 20 - September 20

Marksans Pharma

▲ 44.3

318.35

August 20 - September 20

Syncom Formulations

▲ 39.5

22.71

August 20 - September 20

Wanbury

▲ 38.6

278.79

August 20 - September 20

Brooks Laboratories

▲ 33.6

147.47

August 20 - September 20

Nectar Lifesciences

▲ 29.9

42.25

August 20 - September 20

Biofil Chem & Pharma

▲ 29.7

83.6

August 20 - September 20

Announcing Stock of the Month!

 

Phone

Registered Users

10 lacs

Google Rating

4.6